Avidity of Polyclonal Antibodies to Foot-and-Mouth Disease Virus in Bovine Serum Measured Using Bio-Layer Interferometry.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
29 03 2022
Historique:
received: 31 01 2022
revised: 02 03 2022
accepted: 17 03 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 27 4 2022
Statut: epublish

Résumé

Foot-and-mouth disease (FMD) is a disease of cloven-hoofed livestock caused by FMD virus (FMDV). FMD can be controlled through the use of inactivated vaccines, and it is well established that the protection afforded by FMD vaccines correlates strongly with neutralising antibody titres. However, the overall strength of binding, referred to as avidity, is also an important parameter with respect to the ability of antibodies to neutralise virus infection, and there is evidence that avidity can affect the level of protection afforded by FMDV vaccines. Here, as an alternative to modified enzyme-linked immunosorbent assays (avidity ELISAs) incorporating a chaotropic wash step, we used bio-layer interferometry (BLI) to measure the avidity of bovine polyclonal antibodies against FMDV capsids. We conducted preliminary experiments using recombinant FMDV capsids, as well as peptides representing antigenic loops, to demonstrate that the binding of monoclonal antibodies targeting specific antigenic sites could be detected using BLI. Subsequent experiments using polyclonal sera derived from FMD vaccinated cattle provided evidence of a positive correlation between the neutralising titre of the serum and the avidity as measured by BLI. Furthermore, we observed an increase in BLI avidity, as well as in the titre, in vaccinated animals upon challenge with the live virus.

Identifiants

pubmed: 35458444
pii: v14040714
doi: 10.3390/v14040714
pmc: PMC9027280
pii:
doi:

Substances chimiques

Antibodies, Viral 0
Viral Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/S506680/1
Pays : United Kingdom

Références

PLoS Pathog. 2021 Apr 28;17(4):e1009507
pubmed: 33909694
Expert Rev Vaccines. 2016;15(3):295-311
pubmed: 26641943
J Virol. 2015 Jun;89(11):5981-95
pubmed: 25810537
Prev Vet Med. 2013 Nov 1;112(3-4):161-73
pubmed: 23958457
Virus Evol. 2021 Mar 19;7(1):veab009
pubmed: 35186323
J Immunol. 1991 Jan 15;146(2):749-55
pubmed: 1702816
Vaccine. 2012 Nov 6;30(48):6845-50
pubmed: 23000129
J Virol. 2008 Jul;82(14):7223-30
pubmed: 18448530
J Gen Virol. 1993 Aug;74 ( Pt 8):1547-53
pubmed: 8393912
Curr Opin Immunol. 2020 Aug;65:89-96
pubmed: 32755751
Vaccine. 2014 Jan 16;32(4):433-6
pubmed: 24342253
Vaccine. 2008 Mar 20;26(13):1681-7
pubmed: 18313814
PLoS One. 2018 Oct 12;13(10):e0205102
pubmed: 30312318
J Virol. 1997 Apr;71(4):2606-14
pubmed: 9060612
J Gen Virol. 1989 Mar;70 ( Pt 3):639-45
pubmed: 2471793
Sci Rep. 2020 Dec 10;10(1):21738
pubmed: 33303951
PLoS One. 2017 Sep 26;12(9):e0185184
pubmed: 28949998
Vaccine. 2003 Sep 8;21(25-26):3751-6
pubmed: 12922108
Front Immunol. 2019 Dec 06;10:2870
pubmed: 31867017
Clin Dev Immunol. 2013;2013:475960
pubmed: 24454475
Vaccine. 2017 May 9;35(20):2761-2765
pubmed: 28396208
Vaccine. 2019 Sep 3;37(37):5515-5524
pubmed: 31405637
PLoS Pathog. 2013 Mar;9(3):e1003255
pubmed: 23544011
Vaccine. 1992;10(10):699-706
pubmed: 1326146
J Gen Virol. 2013 Mar;94(Pt 3):559-569
pubmed: 23197575
J Virol. 2000 Jun;74(11):4949-56
pubmed: 10799568
J Immunol. 2018 Aug 15;201(4):1315-1326
pubmed: 30006374
J Clin Microbiol. 2020 May 26;58(6):
pubmed: 32188689
J Immunol Methods. 2017 Nov;450:1-9
pubmed: 28689695
J Gen Virol. 1987 Jun;68 ( Pt 6):1637-47
pubmed: 2438378
Vaccines (Basel). 2020 Jan 10;8(1):
pubmed: 31936706
PLoS One. 2016 Aug 05;11(8):e0160696
pubmed: 27494135
Nature. 1982 Jul 1;298(5869):30-3
pubmed: 7045684
Vaccine. 1997 Apr-May;15(6-7):624-30
pubmed: 9178462
Cell. 2018 Aug 9;174(4):938-952.e13
pubmed: 30096313
J Gen Virol. 2014 May;95(Pt 5):1104-1116
pubmed: 24584474
Immunology. 1988 Oct;65(2):187-91
pubmed: 2847979
Nat Rev Immunol. 2018 Jan;18(1):46-61
pubmed: 29063907
J Gen Virol. 2015 May;96(Pt 5):1033-1041
pubmed: 25614587
Nature. 1983 Dec 15-21;306(5944):694-7
pubmed: 6318114

Auteurs

Andrew E Shaw (AE)

The Pirbright Institute, Pirbright, Woking GU24 0NF, UK.

Alison Burman (A)

The Pirbright Institute, Pirbright, Woking GU24 0NF, UK.

Amin Asfor (A)

The Pirbright Institute, Pirbright, Woking GU24 0NF, UK.
Department of Pathology and Infectious Diseases, Faculty of Health and Medical Sciences, School of Veterinary Medicine, University of Surrey, Guilford GU2 7AL, UK.

Emiliana Brocchi (E)

Istituto Zooprofilattico Sperimentale della Lombardia e Dell'Emilia Romagna "Bruno Ubertini", 25124 Brescia, Italy.

Santina Grazioli (S)

Istituto Zooprofilattico Sperimentale della Lombardia e Dell'Emilia Romagna "Bruno Ubertini", 25124 Brescia, Italy.

Clare Browning (C)

The Pirbright Institute, Pirbright, Woking GU24 0NF, UK.

Anna Ludi (A)

The Pirbright Institute, Pirbright, Woking GU24 0NF, UK.

Tobias J Tuthill (TJ)

The Pirbright Institute, Pirbright, Woking GU24 0NF, UK.

Donald P King (DP)

The Pirbright Institute, Pirbright, Woking GU24 0NF, UK.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH